The company’s mean estimate for sales for the current quarter ending Jun-16 is 105.88 million by 6 analysts. The means estimate of sales for the year ending Dec-16 is 444.24 million by 7 analysts.
The mean price target for the shares of Adeptus Health Inc (NYSE:ADPT) is at 93.63 while the highest price target suggested by the analysts is 125.00 and low price target is 80.00. The mean price target is calculated keeping in view the consensus of 8 brokerage firms.
The average estimate of EPS for the current fiscal quarter for Adeptus Health Inc (NYSE:ADPT) stands at 0.56 while the EPS for the current year is fixed at 2.64 by 7 analysts.
The next one year’s EPS estimate is set at 3.87 by 7 analysts while a year ago the analysts suggested the company’s EPS at 2.64. The analysts also projected the company’s long-term growth at 80.80% for the upcoming five years.
In its latest quarter ended on 31st March 2016, Adeptus Health Inc (NYSE:ADPT) reported earnings of $0.47. The posted earnings topped the analyst’s consensus by $0.07 with the surprise factor of 17.50%. In the matter of earnings surprises, the term “Cockroach Effect” is often implied. Cockroach Effect is a market theory that suggests that when a company reveals bad news to the public, there may be many more related negative events that have yet to be revealed. In the case of earnings surprises, if a company is suggesting a negative earnings surprise it means there are more to come.
Adeptus Health Inc. owns and operates a network of independent freestanding emergency rooms in the United States. As of December 31, 2015, it operated 81 facilities located in the Houston, Dallas/Fort Worth, San Antonio, Austin, Colorado Springs, Denver, and Phoenix. The company was founded in 2002 and is based in Lewisville, Texas.
0 yorum:
Yorum Gönder